Global Insulin Market – Industry Trends and Forecast to 2027

  • Healthcare
  • Upcoming Report
  • Apr 2020
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Insulin Market By Product Type (Intermediate Acting Insulin, Short Acting Insulin, Rapid Acting Insulin, Long Acting Insulin), Source (Human Recombinant Insulin, Insulin Analogs), Disease Type (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes, Prediabetes), Delivery Devices (Syringes, Pens, Pumps, Others), End Users (Home Healthcare, Hospitals, Over The Counter (OTC), Clinics, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa), Market Trends and Forecast to 2027.

Insulin Market

Market Analysis and Insights: Global Insulin Market

Insulin market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to USD 55.006 billion by 2027 growing with the CAGR of 6.85% in the above-mentioned forecast period. The growing awareness amongst the patients regarding the benefits of insulin will help in driving the growth of the market.

Surging volume of patients suffering from diabetes, growing cases of obesity among the geriatric population, rising awareness among the people regarding the benefits of insulin, initiatives taken by government for the provision of better healthcare activities are some of the factors that will likely to enhance the growth of the insulin market in he forecast period of 2020-2027. On the other hand, growing number of development activities related to insulin delivery system along with rising patient population suffering from diabetes will further boost various opportunities that will lead to the growth of insulin market in the above mentioned forecast period.

Increasing cost of insulin along with lack of favourable insurance policies and rising competition among the existing manufacturers will hamper the growth of the insulin market in the above mentioned forecast period.

This insulinmarket report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growth, application niches and dominance, product approvals, product launches, geographical expansions, technological innovations in the market. To gain more info on insulinmarket contact Data Bridge Market Research for an Analyst Brief,our team will help you take an informed market decision to achieve market growth.

Global Insulin Market Scope and Market Size

Insulin market is segmented on the basis of product type, source, delivery process, disease type, and end users. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

  • Based on product type, the insulin market is segmented into intermediate acting insulin, short acting insulin, rapid acting insulin, and long acting insulin.Rapid acting insulin has been further segmented into insulin lispro, insulin aspart, and insulin glulisine. Long acting insulin has been further segmented into insulin detemir, insulin degludec, and insulin glargine. Intermediate acting insulin has been further segmented as humulin N.
  • On the basis of source, the insulin market is segmented into human recombinant insulin, and insulin analogs
  • Based on disease type, the insulin market is segmented into type 1 diabetes, type 2 diabetes, gestational diabetes, and prediabetes
  • On the basis of delivery process, the insulin market is segmented into syringes, pens, pumps, and others
  • Insulin market has also been segmented based onthe end users into home healthcare, hospitals, over the counter (OTC), clinics, and others

Insulin Market Country Level Analysis

Insulin market is analysed and market size insights and trends are provided by country, product type, source, disease type, delivery processand end users as referenced above.

The countries covered in the insulin market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa(MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the insulin market due to the high prevalence of diabetes patients along with rising research activities in the region and provision of various manufacturers, while Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2020 to 2027 due to the growing geriatric population along with rising occurrences of diabetes among the growing population, rising awareness among the people regarding the benefits of insulin and surging levels of investment for the development of advanced and technical product.

The country section of the insulin market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

Insulin market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for insulin market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the insulin market. The data is available for historic period 2010 to 2018.

Competitive Landscape and Insulin Market Share Analysis

Insulin market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to insulin market.

The major players covered in the insulin market report are Sanofi, Takeda Pharmaceutical Company Limited., Novo Nordisk A/S, Bristol Myers Squibb Company, Novartis AG, Eli Lilly and Company., Oramed, dongbao, Biocon., ADOCIA, Julphar, Pfizer Inc., Merck & Co., Inc., GlaxoSmithKline plc., MannKind Corporation, Zhuhai United Laboratories Co., Ltd.,among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa(MEA) and South America separately. DBMR analystsunderstand competitive strengths and provide competitive analysis for each competitor separately.

Customization Available: Global Insulin Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

Please fill in the below form for detailed Table of Content

Please fill in the below form for detailed List of Table

Please fill in the below form for detailed List of Figure

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
BUY NOW ADD TO CART
Why Choose Us
REQUEST FOR SAMPLE